SCHEMBL3961877

SCHEMBL3961877

O=c1cc2ccccc2nnc1I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
MAPT P10636 2/20 0.43
GLA P06280 2/20 0.43
ACHE P22303 1/20 0.43
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
PDE2A O00408 2/20 0.37
PDE3B Q13370 2/20 0.37
PDE3A Q14432 2/20 0.37
NQO2 P16083 1/20 0.37
GPR3 P46089 1/20 0.34
CYP1A2 P05177 1/20 0.34
MGAM O43451 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
GAA P10253 2/20 0.33
IKBKB O14920 1/20 0.33
HTR3A P46098 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9415849 0.80 IKBKB (0.44) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL3244658 0.76 KDM4E (0.44) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL11389056 0.76 KDM4E (0.44) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL19001490 0.74 ALDH1A1 (0.50) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL276035 0.70 ALDH1A1 (0.50) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL9934343 0.69 KDM4E (0.46) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL31115164 0.69 ALDH1A1 (0.55) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL5483645 0.69 ALDH1A1 (0.55) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL11400875 0.68 KDM4E (0.44) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL17506376 0.68 KDM4E (0.44) KDM4EALDH1A1HPGDMAPTGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009037302-A1 5-SUBSTITUTED-1, 4-BENZ0DIAZEPINES AS PHOSPHODIESTERASE INHIBITORS VIA PHARMACEUTICALS, INC. (US) 2009-03-26 WO disclosed
US-6559141-B2 Inhibit beta-amyloid peptide release and/or synthesis, use in treating Alzheimer's disease; for example, 5-(N'-(phenylacetyl)-L-alpha-(2-thienyl)glycinyl)-amino-7-methyl-5,7-dihydro-6H-dibenz(b, d)azepin-6-one ATHENA NEUROSCIENCES, INC. 2003-05-06 US disclosed